Latest News

Vitestro raises €12m in Series A financing

© pixabay.com/Sabinurce


by tg

With assets of €12m through a Series A financing, Dutch Vitestro NV aims to bring the world's first autonomous blood drawing device to the market.

California-based Sonder Capital led the Series A financing round alongside existing investors and new private investors. According to Vitestro, the proceeds will be used to accelerate product development, prepare EU market authorisation, and initiate production of the robotic blood drawing device.

Autonomous blood drawing is closing the gap of of skilled healthcare workers in performing the billions of blood draws annually. Vitestro’s device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion, ensuring accurate and secure blood collection. A prototype has been tested on more than 1,000 patients. Clinical studies will continue in 2023, and European market introduction is anticipated in 2024.

LSP Dementia Fund closes at €260m

Investors included the Alzheimer’s Association, the European Investment Fund EIF, several unnamed global pharmaceutical, and insurance companies,...

uniQure sells royalty interest in gene therapy for $400m

LanzaTech and Plastipak produce greener PET

The PPKNatura resin might safe up to 30% carbon emissions because it replaces petroleum-based monoethylene glycol (MEG), together with terephtalic...

German-Chinese ADC collaboration

Under the terms of the agreement, DualityBio (Shanghai) cashes in $170m upfront plus potential milestones of about $1.5bn. Additionally, DualityBio...

FAO presents food safety assessment on cell-based protein products

With more than 100 companies, including Israel's Aleph Farms, Holland's Mosa Meat and the UK's Higher Steaks Ltd., active in the future market of...

DiogenX SA raises €27.5M in Series A financing

The Marseille-based specialist for beta cell regeneration announced it want to use the proceeds to advance its first-in-class regenerative treatment...

Iktos SA raises €15.5m in Series A financing

aThe Series A financing of Iktos was co-led by new investors M Ventures and Debiopharm Innovation Fund with participation...